Article
Synthesis and biological evaluation of novel 5,6-dihydrobenzo[h]quinazoline derivatives as FLT3 inhibitors.
Chemical biology & drug design - 1 Apr 2022
Ding Lei, Zhang Qing, Zhao Kuantao, Jiao Xiaoyu, Zhou Ying, Fan Weizheng, Tang Chunlei
Abstract excerpt
Fms-like tyrosine kinase 3 (FLT3) is widely expressed and often mutated in acute myeloid leukemia (AML), which makes it an important target for the treatment of AML. The structure-based synthesis and biological evaluation of 5,6-dihydrobenzo[h]quinazoline derivatives as FLT3 inhibitors have been studied in this paper. III-1a, III-1c, III-2a, III-2c, and III-4a displayed comparable inhibitory potency against...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
